Theravance Biopharma, Inc. (TBPH) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | 73.28M | -6.06M | -6.51M | 208.07M | 43.04M | -902K | -5.2M | -4.42M | -1.02M | -854K | -2.49M | -12.44M | -11.22M | -124.06M | -22.14M | -14.73M | -26.07M | -42.43M | -45.45M | -50.11M |
| Operating CF Margin % | 414.03% | -13.21% | -32.56% | 794.33% | 279.69% | -4.81% | -30.8% | -30.97% | -7.05% | -4.86% | -15.84% | -90.45% | -107.72% | -846.85% | -177.79% | -133.3% | -197.55% | -283.92% | -344.44% | -388.05% |
| Operating CF Growth % | 70.26% | -572.28% | -25.25% | 4812.89% | 4311.25% | -5.62% | -109.01% | 64.5% | 90.89% | 99.31% | 88.77% | 15.57% | 56.96% | -192.35% | 51.29% | 70.61% | 62.69% | 34.64% | 41% | 6.06% |
| Net Income | -4.93M | 61.02M | 3.62M | 54.84M | -13.58M | -15.53M | -12.7M | -16.53M | -11.66M | -8.51M | -8.95M | -15.64M | -22.09M | -14.26M | -15.52M | -22.79M | -40.26M | -32.03M | -75.17M | -52.41M |
| Depreciation & Amortization | 1.44M | 430K | 636K | 927K | 1.05M | 695K | 762K | 979K | 1.18M | 1.42M | 937K | 924K | 978K | 2.02M | 1.77M | 1.91M | 1.32M | 2.39M | 2.61M | 2.42M |
| Stock-Based Compensation | 0 | 4.48M | 4.58M | 4.54M | 4.88M | 5.83M | 4.96M | 5.38M | 5.23M | 5.82M | 6.26M | 6.26M | 7.02M | 6.95M | 8.53M | 9.71M | 14.54M | 16.92M | 14.37M | 14.94M |
| Deferred Taxes | -3M | 30K | 994K | -10.69M | -1.85M | -6.59M | 90K | -561K | -513K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 3.94M | -333.7M | 551K | 664K | 604K | 806K | 2.03M | 3.63M | 629K | 3.83M | 610K | 1.89M | 579K | -178.33M | -1.69M | -5.53M | 2.27M | -22.19M | 20.45M | -1.98M |
| Working Capital Changes | 75.83M | 261.67M | -16.88M | 157.8M | 51.94M | 13.89M | -342K | 2.69M | 4.12M | -3.41M | -1.34M | -5.87M | 2.29M | 59.56M | -15.23M | 1.97M | -3.95M | -7.52M | -7.71M | -13.09M |
| Change in Receivables | 79.95M | 99.61M | 3.65M | -6.57M | 53.09M | -1.59M | -2.55M | 365K | 2.81M | -417K | -1.26M | -3.53M | 4.51M | -2.67M | -1.63M | -211K | 1.79M | -64K | -1.78M | -305K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.47M | 355K | 538K | -733K | 166K | 788K | -220K | -2K | 184K | -348K | 271K | -919K | 1M | -3.76M | 2.18M | 1.59M | -1.62M | -5.74M | -1.82M | 5.1M |
| Cash from Investing | 52.59M | 588K | -100.25M | -36.26M | 30.63M | 15.69M | -17.4M | -3.03M | 17.03M | -677K | -21K | 11.05M | -43.05M | 39.16M | 1.08B | 7.51M | 31.92M | 10.82M | -35.79M | 35.77M |
| Capital Expenditures | 0 | -8K | 0 | -34K | 0 | -190K | -15K | -36K | -91K | -677K | -21K | -852K | -938K | -266K | 57K | -113K | -250K | -444K | -1.04M | -156K |
| CapEx % of Revenue | - | 0.02% | - | 0.13% | - | 1.01% | 0.09% | 0.25% | 0.63% | 3.85% | 0.13% | 6.2% | 9% | 1.82% | 0.46% | 1.02% | 1.89% | 2.97% | 7.87% | 1.21% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.3M | 210K | 0 | 1.1B | 17K | 1.85M | 0 | 6K | 0 |
| Cash from Financing | -5.58M | -1.49M | -400K | -503K | -854K | -365K | -372K | -44K | -1.72M | -30.61M | -31.4M | -80.68M | -56.24M | -35.47M | -722.03M | 140K | -1.45M | 149K | -2.29M | 105.28M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -631.6M | 0 | 0 | 0 | 0 | -5.03M |
| Equity Issued (Net) | -5.58M | -1.49M | -400K | -503K | -854K | -498K | -372K | -419K | -1.72M | -30.78M | -31.4M | -81.13M | -56.24M | -35.79M | -94.7M | -347K | -1.45M | -455K | -2.29M | 107.45M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -5.82M | -1.98M | -678K | -503K | -874K | -528K | -397K | -463K | -1.72M | -30.78M | -31.4M | -81.13M | -56.24M | -35.79M | -94.7M | -347K | -1.45M | -455K | -2.29M | -727K |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 133K | 0 | 375K | 0 | 173K | -1K | 446K | 0 | 314K | 4.28M | 487K | 0 | 604K | 0 | 2.86M |
| Net Change in Cash | 120.3M | -6.97M | -107.15M | 171.31M | 72.82M | 14.42M | -22.97M | -7.49M | 14.29M | -32.14M | -33.91M | -82.07M | -110.51M | -120.37M | 331.25M | -7.08M | 4.41M | -31.46M | -83.53M | 90.94M |
| Free Cash Flow | 73.28M | -6.07M | -6.51M | 208.04M | 43.04M | -1.09M | -5.21M | -4.45M | -1.11M | -1.53M | -2.51M | -13.29M | -12.16M | -124.32M | -22.08M | -14.84M | -26.32M | -42.88M | -46.48M | -50.27M |
| FCF Margin % | 414.03% | -13.23% | -32.56% | 794.2% | 279.69% | -5.82% | -30.89% | -31.22% | -7.67% | -8.72% | -15.98% | -96.65% | -116.72% | -848.67% | -177.34% | -134.33% | -199.45% | -286.89% | -352.32% | -389.26% |
| FCF Growth % | 70.26% | -456.04% | -24.89% | 4774.01% | 3966.94% | 28.67% | -107.86% | 66.5% | 90.85% | 98.77% | 88.65% | 10.48% | 53.8% | -189.94% | 52.5% | 70.47% | 63.26% | 35.2% | 41.22% | 9.77% |
| FCF per Share | 1.43 | -0.11 | -0.13 | 4.10 | 0.87 | -0.02 | -0.11 | -0.09 | -0.02 | -0.03 | -0.05 | -0.23 | -0.19 | -1.84 | -0.29 | -0.19 | -0.35 | -0.58 | -0.63 | -0.77 |
| FCF Conversion (FCF/Net Income) | -14.85x | -0.10x | -1.80x | 3.79x | -3.17x | 0.06x | 0.41x | 0.27x | 0.09x | 0.10x | 0.28x | 0.79x | 0.51x | 11.97x | -0.02x | 1.80x | 1.00x | 1.32x | 1.29x | 0.96x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.12M | 10.51M | 4.61M | 13.06M | 4.46M | 8.11M |
| Taxes Paid | 0 | 0 | 0 | 8.9M | 4K | 97K | 0 | 0 | 0 | 10K | 0 | 7K | 7K | 117.94M | 1K | 25K | 0 | 0 | 3.8M | 12K |